|
|
Article: Genentech Reports 35 Percent Increase in Non-GAAP Earnings Per Share for Second Quarter; 23 Percent Increase In Product Sales.
- Article from:
- Business Wire
- Article date:
- July 9, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 9, 2003
Genentech, Inc. (NYSE:DNA) today announced a 35 percent increase in non-GAAP (formerly pro forma) earnings per share for the second quarter of 2003 driven by a 23 percent increase in product sales. Genentech's non-GAAP earnings per share and non-GAAP net income exclude certain charges related to the 1999 Roche redemption of Genentech's stock and certain litigation-related special charges. These charges are itemized in the reconciliation tables below.
For the three months ended June 30, 2003:
-- Non-GAAP earnings per ...